Next Article in Journal
Matrix-Encoding Gene Diversity of 624 Influenza A/H3N2 Genomes Does Not Show Association with Impaired Viral Detection by Commercialized qPCR Assays
Previous Article in Journal
Advances in Molecular Genetics Enabling Studies of Highly Pathogenic RNA Viruses
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients

1
Department of Microbiology & Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA
2
Department of Internal Medicine, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA
3
Department of Public Health, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA
*
Author to whom correspondence should be addressed.
Viruses 2022, 14(12), 2681; https://doi.org/10.3390/v14122681
Submission received: 8 October 2022 / Revised: 20 November 2022 / Accepted: 25 November 2022 / Published: 30 November 2022
(This article belongs to the Section SARS-CoV-2 and COVID-19)

Abstract

Wide variability exists with host response to SARS-CoV-2 infection among individuals. Circulatory micro RNAs (miRNAs) are being recognized as promising biomarkers for complex traits, including viral pathogenesis. We hypothesized that circulatory miRNAs at 48 h post hospitalization may predict the length of stay (LOS) and prognosis of COVID-19 patients. Plasma miRNA levels were compared between three groups: (i) healthy volunteers (C); (ii) COVID-19 patients treated with remdesivir (an antiviral) plus dexamethasone (a glucocorticoid) (with or without baricitinib, a Janus kinase inhibitor) on the day of hospitalization (I); and COVID-19 patients at 48 h post treatment (T). Results showed that circulatory miR-6741-5p expression levels were significantly different between groups C and I (p < 0.0000001); I and T (p < 0.0000001); and C and T (p = 0.001). Our ANOVA model estimated that all patients with less than 12.42 Log2 CPM had a short LOS, or a good prognosis, whereas all patients with over 12.42 Log2 CPM had a long LOS, or a poor prognosis. In sum, we show that circulatory miR-6741-5p may serve as a prognostic biomarker effectively predicting mortality risk and LOS of hospitalized COVID-19 patients.
Keywords: SARS-CoV-2; miRNA; biomarker; COVID-19; LOS SARS-CoV-2; miRNA; biomarker; COVID-19; LOS

Share and Cite

MDPI and ACS Style

Akula, S.M.; Williams, J.F.; Pokhrel, L.R.; Bauer, A.N.; Rajput, S.; Cook, P.P. Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients. Viruses 2022, 14, 2681. https://doi.org/10.3390/v14122681

AMA Style

Akula SM, Williams JF, Pokhrel LR, Bauer AN, Rajput S, Cook PP. Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients. Viruses. 2022; 14(12):2681. https://doi.org/10.3390/v14122681

Chicago/Turabian Style

Akula, Shaw M., John F. Williams, Lok R. Pokhrel, Anais N. Bauer, Smit Rajput, and Paul P. Cook. 2022. "Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients" Viruses 14, no. 12: 2681. https://doi.org/10.3390/v14122681

APA Style

Akula, S. M., Williams, J. F., Pokhrel, L. R., Bauer, A. N., Rajput, S., & Cook, P. P. (2022). Cellular miR-6741-5p as a Prognostic Biomarker Predicting Length of Hospital Stay among COVID-19 Patients. Viruses, 14(12), 2681. https://doi.org/10.3390/v14122681

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop